Weiss Asset Management LP[1 »

Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Weiss Asset Management LP[1

Quarter-by-quarter ownership of Sarepta Therapeutics Inc Note 1.250 9/1 shares owned by Weiss Asset Management LP[1 from 13F filings

Historical chart of Weiss Asset Management LP[1 investment in Sarepta Therapeutics Inc Note 1.250 9/1

Tip: Access up to 7 years of quarterly data

All positions including Sarepta Therapeutics Inc Note 1.250 9/1 held by Weiss Asset Management LP[1 consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sarepta Therapeutics Inc Note 1.250 9/1 by Weiss Asset Management LP[1

Quarter filed Position value Share count Share price at filing
2023-12-31 $6.3M 6.3M 1.01

More positions owned by Weiss Asset Management LP[1

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Splunk Note 1.125% 9/1 (Principal)
Theravance Biopharma (TBPH)
Cytokinetics Note 3.500% 7/0 (Principal)
Tesla Motors Call Option (TSLA)
American Airls Put Option (AAL)
Nextera Energy (NEE)
Vnet Group Note 2/0 (Principal)
Atmus Filtration Technologies Ord (ATMU)
Li Auto Note 0.250% 5/0 (Principal)
Bridgebio Pharma Note 2.250% 2/0 (Principal)
Ares Capital Corp Note 4.625% 3/0 (Principal)
CRH Ord Put Option (CRH)
Coinbase Global Com Cl A Put Option (COIN)
NiSource (NI)

View all positions for Weiss Asset Management LP[1

Top funds holding Sarepta Therapeutics Inc Note 1.250 9/1

Wolverine Asset Management
Calamos Advisors
Braidwell
Highbridge Capital Management
Davidson Kempner Capital Management
Readystate Asset Management
Bank of America Corporation
Lazard Asset Management
Tenor Capital Management
D. E. Shaw & Co
Bank Of Montreal
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Steelhead Partners
Context Capital Management
Capstone Investment Advisors

View all funds holding Sarepta Therapeutics Inc Note 1.250 9/1